Guangzhou Suwei Bio-technology Co.,Ltd – Trademark Portfolio

Entity Type: 99

Guangzhou Suwei Bio-technology Co.,Ltd holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 1 filings in this category. The portfolio also extends into Class 21 (Housewares) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include DAWNCOMES. The owner is based in Guangzhou.

8-12, No.133,Yanling Rd,Tianhe Dist

Guangzhou 510000 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Guangzhou Suwei Bio-technology Co.,Ltd's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (1 filing)

Clothing, footwear, headgear

21
Housewares (1 filing)

Household or kitchen utensils and containers; combs and sponges; brushes

Frequently Asked Questions

How many trademarks does Guangzhou Suwei Bio-technology Co.,Ltd have?

Guangzhou Suwei Bio-technology Co.,Ltd has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Guangzhou Suwei Bio-technology Co.,Ltd file in?

Guangzhou Suwei Bio-technology Co.,Ltd files trademarks across 2 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 21 (Housewares). Class 25 covers clothing, footwear, headgear.

What are Guangzhou Suwei Bio-technology Co.,Ltd's most well-known trademarks?

Guangzhou Suwei Bio-technology Co.,Ltd's registered trademark portfolio includes well-known marks such as DAWNCOMES. These are among 2 currently registered trademarks in the portfolio.

What is Guangzhou Suwei Bio-technology Co.,Ltd's trademark registration success rate?

Guangzhou Suwei Bio-technology Co.,Ltd has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.